EUVIMEDEUVIMED entdecken
Crossref

Effect of midodrine on HVPG in advanced chronic liver disease and acute‐on‐chronic liver failure—A pilot study

Chitranshu Vashishtha iD, Ankit Bhardwaj, Ankur Jindal iD, Manoj Kumar iD, Shiv Kumar Sarin iD

Liver International · 2024

DOI: 10.1111/liv.16033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Chitranshu Vashishtha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Midodrine, Acute-On-Chronic Liver Failure, Hypertension, Portal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Nonselective beta‐blockers (NSBB) are the mainstay for treatment of portal hypertension (PH), but require caution in decompensated cirrhosis (DC) or acute‐on‐chronic liver failure (ACLF) with hypotension, hyponatremia, acute kidney injury (AKI) or type 2 hepatorenal syndrome (HRS). Midodrine is oral, rapidly acting, α1‐adrenergic agonist. We evaluated acute effects of midodrine on hepatic venous pressure gradient (HVPG) in DC and ACLF with contraindications to NSBB. Methods Patients of DC ( n = 30) with grade III ascites and serum sodium (Na)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MidodrineAcute-On-Chronic Liver FailureHypertension, PortalHumansPilot ProjectsFemaleMaleMiddle AgedLiver CirrhosisAdrenergic alpha-1 Receptor AgonistsAdultAgedTreatment OutcomeProspective StudiesPortal Pressure

Stichwörter der Autor:innen

HVPGacute kidney injuryhepatorenal syndromehyponatremiamean arterial pressure

Substanzen

MidodrineAdrenergic alpha-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Department of Epidemiology and Public Health, Institute of Liver and Biliary Sciences, New Delhi, India.

ORCID-Profile: Chitranshu Vashishtha, Ankur Jindal, Manoj Kumar, Shiv Kumar Sarin

Zitieren

APA

Vashishtha, C., Bhardwaj, A., Jindal, A., Kumar, M., & Sarin, S. K. (2024). Effect of midodrine on HVPG in advanced chronic liver disease and acute‐on‐chronic liver failure—A pilot study. Liver International. https://doi.org/10.1111/liv.16033

Vancouver

Vashishtha C, Bhardwaj A, Jindal A, Kumar M, Sarin SK. Effect of midodrine on HVPG in advanced chronic liver disease and acute‐on‐chronic liver failure—A pilot study. Liver International. 2024. doi:10.1111/liv.16033

BibTeX
@article{Vashishtha2024,
  author = {Vashishtha, Chitranshu and Bhardwaj, Ankit and Jindal, Ankur and Kumar, Manoj and Sarin, Shiv Kumar},
  title = {Effect of midodrine on HVPG in advanced chronic liver disease and acute‐on‐chronic liver failure—A pilot study},
  journal = {Liver International},
  year = {2024},
  doi = {10.1111/liv.16033}
}
Kostenlos starten →